From: Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome
 | CFS | Non-Fatigued |
---|---|---|
Atlanta Case Control | Â | Â |
Subjects (n = 56) | 22 | 34 |
Female (n = 52) | 19 | 33 |
Male (n = 4) | 3 | 1 |
Age Group (yrs) | Â | Â |
18–29 (n = 9) | 3 | 6 |
30–39 (n = 18) | 7 | 11 |
40–49 (n = 23) | 12 | 11 |
50–59 (n = 6) | 0 | 6 |
Mean Age | 39 years | 38 years |
Mean Age Onset | 35 years | Â |
Onset type | Â | Â |
   Sudden | 8 |  |
   Gradual | 14 |  |
Mean Illness Duration | 69 months | Â |
Number of Subjects Ill | Â | Â |
   < 5 years | 10 |  |
   >5 years | 12 |  |
Wichita Population | Â | Â |
Subjects (n = 94) | 37 | 57 |
Female (n = 64) | 31 | 33 |
Male (n = 30) | 6 | 24 |
Age Group (yrs) | Â | Â |
18–29 (n = 14) | 1 | 13 |
30–39 (n = 18) | 8 | 10 |
40–49 (n = 26) | 13 | 13 |
50–69 (n = 36) | 15 | 21 |
Mean Age | 46 years | 42 years |
Mean Age Onset | 36 years | Â |
Onset type | Â | Â |
   Sudden | 5 |  |
   Gradual | 32 |  |
Mean Illness Duration | 128 months | Â |
Number of Subjects Ill | Â | Â |
   < 5 years | 14 |  |
   >5 years | 23 |  |